Celestone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosyovitis

Condition:   DeQuervain Tendinopathy
Interventions:   Drug: Celestone;   Drug: Ketorolac
Sponsor:   OrthoCarolina Research Institute, Inc.
Recruiting – verified November 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.